--- title: "Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day" type: "News" locale: "en" url: "https://longbridge.com/en/news/278944439.md" description: "Labcorp Holdings Inc. (LH) shares fell 2.78% to $262.91 on a poor trading day, while the S&P 500 and Dow Jones also declined. Despite this, Labcorp's performance was better than some competitors, with IQVIA down 5.04%, Centene down 3.60%, and Teladoc down 2.01%. Labcorp remains 10.49% below its 52-week high of $293.72 reached on October 21st. Trading volume was 734,820, surpassing the 50-day average of 715,209." datetime: "2026-03-12T21:05:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278944439.md) - [en](https://longbridge.com/en/news/278944439.md) - [zh-HK](https://longbridge.com/zh-HK/news/278944439.md) --- # Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Labcorp Holdings Inc. (LH) shed 2.78% to $262.91 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.52% to 6,672.62 and Dow Jones Industrial Average falling 1.56% to 46,677.85. Labcorp Holdings Inc. closed 10.49% short of its 52-week high of $293.72, which the company reached on October 21st. The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as IQVIA Holdings Inc. (IQV) fell 5.04% to $162.93, Centene Corp. (CNC) fell 3.60% to $34.57, and Teladoc Health Inc. (TDOC) fell 2.01% to $5.36. Trading volume (734,820) eclipsed its 50-day average volume of 715,209. Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 03-12-26 1705ET ### Related Stocks - [EDOC.US](https://longbridge.com/en/quote/EDOC.US.md) - [CNC.US](https://longbridge.com/en/quote/CNC.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md) - [IQV.US](https://longbridge.com/en/quote/IQV.US.md) - [FDHT.US](https://longbridge.com/en/quote/FDHT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [LH.US](https://longbridge.com/en/quote/LH.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) ## Related News & Research - [Labcorp Holdings Inc. (NYSE:LH) Plans Quarterly Dividend of $0.72](https://longbridge.com/en/news/282250116.md) - [Stifel Nicolaus Reaffirms Their Buy Rating on Concurrent Technologies (CNC)](https://longbridge.com/en/news/282906491.md) - [Centene (NYSE:CNC) Issues FY 2026 Earnings Guidance](https://longbridge.com/en/news/282245339.md) - [Labcorp Declares Quarterly Dividend | LH Stock News](https://longbridge.com/en/news/282178980.md) - [Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA](https://longbridge.com/en/news/282576241.md)